Actinium Pharmaceuticals Inc. buy melinda
Start price
28.07.17
/
50%
€15.00
Target price
23.10.17
€36.00
Performance (%)
20.80%
End price
23.10.17
€18.12
Summary
This prediction ended on 23.10.17 with a price of €18.12. The BUY prediction by melinda finished with a performance of 20.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | -7.412% | -7.412% | 14.129% | -86.228% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
Comments by melinda for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
PHARMA
Actinium Pharmaceuticals, Inc. (NYSE Amex: ATNM) ihre Absicht angekündigt , die Aktien und Optionsscheine in einem öffentlichen Angebot Zeichnungs zu verkaufen. Die Aktien gehandelt werden um 19% auf $ 0,79 auf der Sitzung nach Stunden.
Stopped prediction by melinda for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.66
02.12.18
02.12.18
€21.00
21.01.19
21.01.19
-32.76%
21.01.19
21.01.19
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.46
06.05.16
06.05.16
€57.00
31.08.16
31.08.16
6.41%
31.08.16
31.08.16